RE Sobol
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Acute Lymphoblastic Leukemia research 10
- Genetics 9
- Chronic Lymphocytic Leukemia Research 9
- Co-authors
- RK Dodge (4 shared papers)FR Davey (5 shared papers)Richard A. Larson (3 shared papers)EJ Lee (1 shared paper)RM Stone (1 shared paper)Philip Schulman (1 shared paper)SR Frankel (2 shared papers)CP Burns (1 shared paper)
- Journals
- Blood (11 papers)PubMed (4 papers)
- Partner nations
- United States
In The Last Decade
RE Sobol
15 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 57
- Hematology 618
- Genetics 266
- Public Health, Environmental and Occupational Health 672
- Pathology and Forensic Medicine 149
- Immunology 171
Countries citing papers authored by RE Sobol
This map shows the geographic impact of RE Sobol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RE Sobol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RE Sobol more than expected).
Fields of papers citing papers by RE Sobol
This network shows the impact of papers produced by RE Sobol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RE Sobol. The network helps show where RE Sobol may publish in the future.
Co-authors
The 25 scholars most cited alongside RE Sobol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 455 | |
| 2 | 1992 | 200 | |
| 3 | 1982 | 126 | |
| 4 | 1985 | 92 | |
| 5 | 1990 | 67 | |
| 6 | 1990 | 50 | |
| 7 | Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB Study. | 1991 | 48 |
| 8 | Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen. | 1988 | 24 |
| 9 | 1992 | 22 | |
| 10 | Detection of MLL gene rearrangements in adult acute lymphoblastic leukemia. A Cancer and Leukemia Group B study. | 1994 | 13 |
| 11 | Low incidence of TAL1 gene rearrangements in adult acute lymphoblastic leukemia: A cancer and leukemia group B study (8762) | 1995 | 12 |
| 12 | 1990 | 10 | |
| 13 | 1985 | 6 | |
| 14 | 1982 | 3 | |
| 15 | 1990 | 1 |
About RE Sobol
RE Sobol is a scholar working on Public Health, Environmental and Occupational Health, Genetics, Hematology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (10 papers), Chronic Lymphocytic Leukemia Research (9 papers), Acute Myeloid Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Hematology (618 citations), Genetics (266 citations), Public Health, Environmental and Occupational Health (672 citations), Pathology and Forensic Medicine (149 citations) and Immunology (171 citations). RE Sobol has collaborated with scholars based in United States. Frequent co-authors include RK Dodge, FR Davey, Richard A. Larson, EJ Lee, RM Stone, Philip Schulman, SR Frankel, CP Burns, Ivor Royston and Frederick R. Davey. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.